[1]
E. M. Ahmed, A. A. Boseila, A. S. Hanora, and S. M. Solyman, “Human Cathelicidin, LL-37 a potential antiviral therapeutic for Rift Valley Fever Virus in Egypt: Cathelicidin, LL-37 antiviral therapeutic for RVFV”, Cell Mol Biol (Noisy-le-grand), vol. 70, no. 8, pp. 1–9, Sep. 2024.